Evidence map›Paper›PMID 38813014›Full record

ArticleTurkish journal of medical sciences2023

Alterations in B and NK cells highly correlate with disease severity in children with COVID-19.

Ezgi Topyildiz, Neslihan Edeer Karaca, Burcu Taşkin, Ayşe Aygün, Zümrüt Şahbudak Bal, Eylem Ulaş Saz, Nuri Zafer Kurugöl, Necil Kütükçüler, Güzide Aksu

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ezgi TopyildizDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-9260-8157
Neslihan Edeer KaracaDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-2202-7082
Burcu TaşkinDepartment of Pediatric Rheumatology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-1734-8102
Ayşe AygünDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-4422-7595
Zümrüt Şahbudak BalDepartment of Pediatric Infection Disease, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0001-9189-8220
Eylem Ulaş SazDepartment of Pediatric Emergency, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-2555-2712
Nuri Zafer KurugölDepartment of Pediatric Infection Disease, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-1721-3534
Necil KütükçülerDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0002-9196-3819
Güzide AksuDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Ege University, İzmir, Turkiye.ORCID https://orcid.org/0000-0003-2714-0903

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Children with coronavirus disease 2019 (COVID-19) present milder symptoms than adults and are at lower risk of hospitalization and life-threatening complications. However, the kinetics of lymphocyte subsets and serum immunoglobulins in the peripheral blood during COVID-19 infection remains unclear. In this study, it was aimed to determine the changes in hematological and immunological parameters, especially in the lymphocyte subsets, in the peripheral blood of children with different COVID-19 disease severity. Materials and methods: The study was planned as a prospective cohort and included 68 children aged 0-18 years who were admitted to Ege University Faculty of Medicine Department of Pediatrics and diagnosed with COVID-19 infection between May 2020 and December 2021. In addition to demographic characteristics, clinical findings, and severity criteria, hematological, biochemical, and immunological laboratory (T/B lymphocyte subgroups, serum immunoglobulins) results were noted and examined if there were some correlations between disease severity and the laboratory values. Results: In the study group, while 60.6% (n = 40) of the patients received treatment in the hospital, 10.6% (n = 7) needed intensive care treatment. Lymphopenia (35.3%) was more common than neutropenia (14.7%) in the COVID-19-infected children. CD19+ B cells were low in a very high percentage of patients (26.5%), and 16.2% had low levels of NK cells. Significant correlation between disease severity and CD19+lymphocytes, CD19+CD38+IgM Conclusion: As the severity of the disease increased, the CD19

Indexed as

COVID-19Killer Cells, NaturalSeverity of Illness IndexAdolescentB-LymphocytesChildChild, PreschoolFemaleHumansInfantInfant, NewbornLymphocyte CountLymphocyte SubsetsLymphopeniaMaleProspective StudiesB LymphocyteschildrenCOVID-19disease severityimmunologynatural killer cells

Identifiers

PMID38813014
PMCPMC10763789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.